Description
PROSTAMAX
Prostate & Tissue-Specific Peptide Research
Prostamax is described as a short synthetic peptide within the Khavinson-style bioregulatory peptide family.
Experimental research has investigated its relationship with prostate tissue and cellular processes associated with tissue maintenance and aging.
The existing literature is predominantly preclinical, including laboratory and animal research, and controlled human clinical evidence is currently lacking.
Research Focus: Prostate biology • Tissue signaling • Cellular aging • Bioregulatory peptide research
Research Status: Experimental peptide; preclinical evidence predominates.
